Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 45.00
High: 45.00
Low: 45.00
Prev. Close: 45.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Eneraqua shares plunge on annual profit warning

Wed, 11th Oct 2023 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Power Metal Resources PLC, up 8.8% at 0.68 pence, 12-month range 0.55-1.85p. The metals exploration and development company reports that extensive radon gas sampling at the Tait Hill and Soaring Bay projects in and around the Athabasca Basin in Saskatchewan, Canada, have confirmed multiple significant uranium targets. Chief Executive Sean Wade says this season's uranium fieldwork continues to surpass the firm's expectations in terms of quality and number of significant targets discovered. "Following very low acquisition costs, we believe we are now adding very considerable value to a portfolio with well thought out, methodical and inexpensive exploration, clearly demonstrating the ongoing success of our business model. We now look forward to the next stage, that of crystallising the value created for our shareholders. We are in discussion with various third parties about ways in which we can do that, and I look forward to updating shareholders on those discussions in due course," the CEO adds.

----------

Cambridge Cognition Holdings PLC, up 6.7% at 74.70 pence, 12-month range 65.35-129.74p. The company wins a "significant" GBP1 million contract for a "sizeable" later stage clinical trial, following a competitive tender. The contract combines the company's Cantab touch-screen cognitive assessments with verbal assessments from its recent Winterlight Labs acquisition. Cambridge Cognition will supply its electronic clinical outcome assessments and provide full training for clinicians, together with quality control services, as part of the contract. Revenue from the contract is expected to be recognised over a two-year period, starting in 2023. Notes there is potential for a further contract with the same customer, of "slightly" higher value, in 2024 once the initial results have been analysed. Cambridge Cognition develops and markets digital solutions to assess brain health.

----------

AIM - LOSERS

----------

Eneraqua Technologies PLC, down 58% at 39.00 pence, 12-month range 38.26-389.60p. The energy and water efficiency solution provider swings to an interim loss amid rising costs and warns of a "material reduction" in profitability in the full-year. Pretax loss in the six months ended July 31 totals GBP441,000, swinging from a profit of GBP3.0 million the year prior. Loss comes as the company records a 20% rise in its cost of sales to GBP17.2 million, and a 31% rise in administrative expenses to GBP9.0 million. The rising costs offsets growth in revenue which rises 7.4% to GBP26.0 million from GBP24.2 million. Chief Executive Mitesh Dhanak adds: "Post-period end the group has faced dual headwinds. The continued and increased budgetary pressures on local government are leading to discussions on slowing down project delivery and deferring works into [financial 2025]. This compounds the impact of the recent unexpected [UK] government policy change in relation to net nutrient neutrality. As a result, the board now expects some projects to be delivered more slowly with revenues moving into next year and reduced operational leverage affecting margins. As a result we expect to see a material reduction in revenues and outturn in profitability during [financial 2024]."

----------

Jubilee Metals Group PLC, down 11% at 6.26 pence, 12-month range 6.01-13.92p. The metal processing company reports that its annual profit more than halved as surging overhead costs put margins under pressure. Posts a pretax profit of GBP12.3 million in the financial year ended June 30, down 54% from GBP26.5 million a year earlier. Profit margins shrink to 22% from 32%, as costs balloon. Cost of sales grow by 17% to GBP110.5 million from GBP94.6 million. Finance costs multiply to GBP5.2 million from GBP1.4 million. Jubilee reports revenue of GBP141.9 million, up slightly 1.4% from GBP140.0 million, with growth in dollar-denominated chrome revenue predominately offsetting a decrease in platinum group metal revenue. Notes that PGM price is now trading at USD1,359 an ounce, which is 46% below the 2022 financial average and 21% below average in the 2023 financial year.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
15 Jul 2020 16:20

Cambridge Cognition joins Covid healthcare worker investigation

(Sharecast News) - Cambridge Cognition is collaborating with 4YouandMe and the Center for International Emergency Medical Services (CIEMS), it announced on Wednesday, to investigate the use of wearables and mobile phones to measure stress recovery in front line healthcare workers caring for Covid-19 positive patients in the United States.

Read more
15 Jul 2020 11:47

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

Read more
30 Jun 2020 20:26

IN BRIEF: Cambridge Cognition Interim Order Intake Surges Annually

IN BRIEF: Cambridge Cognition Interim Order Intake Surges Annually

Read more
30 Jun 2020 11:00

Cambridge Cognition order intake nearly doubles in H1

(Sharecast News) - Software group Cambridge Cognition has seen its order intake almost double in the six months ended 30 June following the company's switch in focus to having a more diversified portfolio and its efforts to commercialise new products.

Read more
27 May 2020 13:10

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

Read more
27 May 2020 10:08

Cambridge Cognition inks multiple new contracts for virtual trials

(Sharecast News) - Digital brain health products developer Cambridge Cognition has secured several new contracts to support pharmaceutical clients in delivering virtual clinical trials, including two contracts collectively worth over £1m.

Read more
5 May 2020 12:11

Cambridge Cognition 2019 Loss Widens As Revenue Falls On Sales Decline

Cambridge Cognition 2019 Loss Widens As Revenue Falls On Sales Decline

Read more
17 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
17 Mar 2020 16:02

Cambridge Cognition Three Contracts Worth Total Of GBP1.4 Million

Cambridge Cognition Three Contracts Worth Total Of GBP1.4 Million

Read more
2 Mar 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 Feb 2020 09:40

Cambridge Cognition To Raise GBP1.4 Million; Expects Wider Annual Loss

Cambridge Cognition To Raise GBP1.4 Million; Expects Wider Annual Loss

Read more
19 Feb 2020 08:03

Cambridge Cognition losses widen amid sales slump

(Sharecast News) - Digital solutions development group Cambridge Cognition warned on Wednesday that its full-year losses were set to widen after the lower level of sales seen throughout the first half of the year extended into the third quarter

Read more
25 Nov 2019 09:36

Cambridge Cognition gains client with improved electronic assessment platform

(Sharecast News) - Brain health solutions developer Cambridge Cognition Holdings announced the launch of an improved electronic clinical outcomes assessment ('eCOA') platform on Monday, claiming it had already attracted a new client from one of the world's top 10 pharmaceutical companies.

Read more
25 Oct 2019 15:22

Cambridge Cognition hoping to ride coat-tails of Biogen Alzheimer's programme

(Sharecast News) - Cambridge Cognition announced on Friday that, Following a consultation with the US Food and Drug Administration (FDA), Biogen and Eisai have announced plans to pursue regulatory approval for 'aducanumab', which would be the first therapy to tackle clinical decline in early Alzheimer's disease.

Read more
25 Oct 2019 10:37

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.